FI920342A0 - Komplex som innehaoller koaguleringsfaktor ix och foerfarande foer framstaellning daerav. - Google Patents

Komplex som innehaoller koaguleringsfaktor ix och foerfarande foer framstaellning daerav.

Info

Publication number
FI920342A0
FI920342A0 FI920342A FI920342A FI920342A0 FI 920342 A0 FI920342 A0 FI 920342A0 FI 920342 A FI920342 A FI 920342A FI 920342 A FI920342 A FI 920342A FI 920342 A0 FI920342 A0 FI 920342A0
Authority
FI
Finland
Prior art keywords
koaguleringsfaktor
komplex
foerfarande foer
foer framstaellning
och foerfarande
Prior art date
Application number
FI920342A
Other languages
English (en)
Other versions
FI100111B (fi
FI920342L (fi
Inventor
Yendra Linnau
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of FI920342A0 publication Critical patent/FI920342A0/fi
Publication of FI920342L publication Critical patent/FI920342L/fi
Application granted granted Critical
Publication of FI100111B publication Critical patent/FI100111B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/644—Coagulation factor IXa (3.4.21.22)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21022—Coagulation factor IXa (3.4.21.22)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Measurement Of Velocity Or Position Using Acoustic Or Ultrasonic Waves (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Compounds Of Unknown Constitution (AREA)
FI920342A 1991-01-25 1992-01-24 Hyytymistekijää IX sisältävä kompleksi ja menetelmä sen valmistamiseks i FI100111B (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0016391A AT402261B (de) 1991-01-25 1991-01-25 Komplex enthaltend den gerinnungsfaktor ix

Publications (3)

Publication Number Publication Date
FI920342A0 true FI920342A0 (fi) 1992-01-24
FI920342L FI920342L (fi) 1992-07-26
FI100111B FI100111B (fi) 1997-09-30

Family

ID=3483232

Family Applications (1)

Application Number Title Priority Date Filing Date
FI920342A FI100111B (fi) 1991-01-25 1992-01-24 Hyytymistekijää IX sisältävä kompleksi ja menetelmä sen valmistamiseks i

Country Status (12)

Country Link
US (2) US5281661A (fi)
EP (1) EP0496725B1 (fi)
JP (2) JP2651307B2 (fi)
AT (2) AT402261B (fi)
CA (1) CA2059979C (fi)
CZ (2) CZ280297B6 (fi)
DE (1) DE59207638D1 (fi)
DK (1) DK0496725T3 (fi)
ES (1) ES2098485T3 (fi)
FI (1) FI100111B (fi)
HU (1) HU212362B (fi)
SK (2) SK280130B6 (fi)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69231401T2 (de) 1991-03-01 2001-02-08 Rhone-Poulenc Rorer International (Holdings) Inc., Greenville Herstellung von faktor-ix
DE4342132C1 (de) * 1993-12-10 1994-11-03 Octapharma Ag Verfahren zur Herstellung virusinaktivierte Vitamin K abhängige Plasmakomponenten sowie Protein C und Protein S enthaltender Mittel durch Membran-Chromatographie
ES2163519T3 (es) 1994-06-30 2002-02-01 Dade Behring Inc Miembros separadores bioactivos porosos.
US5888826A (en) * 1994-06-30 1999-03-30 Dade Behring Inc. Combination reagent holding and test device
US5602037A (en) * 1994-06-30 1997-02-11 Dade International, Inc. Combination reagent holding and test device
DE19506633A1 (de) * 1995-02-25 1996-08-29 Octapharma Ag Verfahren zur Herstellung von Faktor IX aus biologischen Quellen
US5714583A (en) 1995-06-07 1998-02-03 Genetics Institute, Inc. Factor IX purification methods
US5958716A (en) * 1996-06-06 1999-09-28 Dade Behring Inc. Blood factor assay
KR20010031785A (ko) * 1997-11-05 2001-04-16 가마꾸라 아끼오 헤파린 보조인자 ｉｉ 제제 및 그 제조 방법
WO2005033140A1 (ja) * 2003-09-30 2005-04-14 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute 高純度血液凝固ｉｘ因子調製物およびその精製方法
AU2005260763B2 (en) 2004-06-30 2011-12-22 Nektar Therapeutics Polymer-factor IX moiety conjugates
US9187549B2 (en) * 2004-12-23 2015-11-17 Novo Nordisk Healthcare A/G Reduction of the content of protein contaminants in compositions comprising a vitamin K-dependent protein of interest
EP2762492A3 (en) 2009-05-27 2015-03-18 Baxter International Inc A method to produce a highly concentrated immunoglobulin preparation for subcutaneous use
DK2477603T3 (en) 2009-09-17 2016-06-13 Baxalta Inc STABLE CO-DEVELOPMENT OF hyaluronidase and Immunoglobulin, AND METHODS OF USE THEREOF
CN103282042B (zh) 2010-09-17 2014-12-10 巴克斯特国际公司 通过具有组氨酸的水性制剂在弱酸性至中性pH稳定的免疫球蛋白
JP6088435B2 (ja) 2010-12-15 2017-03-01 バクスアルタ ゲーエムベーハー 導電率グラディエントを用いる溶出液収集
EP2712423A4 (en) 2011-02-25 2015-06-10 Wellstat Diagnostics Llc Assays for detecting enzymatic activity
WO2025068923A2 (en) 2023-09-26 2025-04-03 Takeda Pharmaceutical Company Limited IMMUNOGLOBULIN FORMULATIONS DEPLETED IN IgA

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2543448A1 (fr) * 1983-04-01 1984-10-05 Rhone Poulenc Spec Chim Procede de fractionnement du plasma
US4820805A (en) * 1983-07-14 1989-04-11 New York Blood Center, Inc. Undenatured virus-free trialkyl phosphate treated biologically active protein derivatives
AT389815B (de) * 1984-03-09 1990-02-12 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten
US4721572A (en) * 1985-07-12 1988-01-26 Miles Laboratories, Inc. Purfication of blood clotting factors and other blood proteins on non-carbohydrate sulfated matrices
CA1288711C (en) * 1986-01-06 1991-09-10 Kenneth J. Smith Therapeutic blood product means and methods of preparing same
JPS63108000A (ja) * 1986-05-15 1988-05-12 Green Cross Corp:The 第８因子の精製方法
US4725673A (en) * 1986-08-29 1988-02-16 Alpha Therapeutic Corporation Plasma fraction purification using silica resin bound to a ligand
ES2045167T5 (es) * 1987-10-23 1996-07-01 Centre Regional De Transfusion Preparacion de concentrado de factor ix humano de elevada pureza y de otras proteinas plasmaticas.
DE3914869C1 (fi) * 1989-05-05 1990-08-09 Biotest Pharma Gmbh, 6072 Dreieich, De

Also Published As

Publication number Publication date
EP0496725A3 (en) 1993-05-05
SK280989B6 (sk) 2000-10-09
SK280130B6 (sk) 1999-08-06
FI100111B (fi) 1997-09-30
DE59207638D1 (de) 1997-01-23
HU212362B (en) 1996-06-28
FI920342L (fi) 1992-07-26
JPH04295432A (ja) 1992-10-20
JP2866047B2 (ja) 1999-03-08
EP0496725B1 (de) 1996-12-11
AT402261B (de) 1997-03-25
JP2651307B2 (ja) 1997-09-10
ES2098485T3 (es) 1997-05-01
JPH08259449A (ja) 1996-10-08
CA2059979A1 (en) 1992-07-26
CZ280297B6 (cs) 1995-12-13
US5281661A (en) 1994-01-25
DK0496725T3 (da) 1997-06-09
CZ280725B6 (cs) 1996-04-17
US5409990A (en) 1995-04-25
HUT63863A (en) 1993-10-28
HU9200225D0 (en) 1992-04-28
ATE146220T1 (de) 1996-12-15
CS21192A3 (en) 1992-08-12
ATA16391A (de) 1996-08-15
CZ154794A3 (en) 1996-04-17
CA2059979C (en) 2003-04-15
EP0496725A2 (de) 1992-07-29

Similar Documents

Publication Publication Date Title
FI920342A0 (fi) Komplex som innehaoller koaguleringsfaktor ix och foerfarande foer framstaellning daerav.
SE8206168D0 (sv) Preparations and process for preparation thereof
YU28499A (sh) Novi preparati, lekova rastvorenih u vodi, za dobijanje aerosola bez potisnog gasa
ES2098140T3 (es) Liosferas que contienen gonadotropina.
DE59009451D1 (de) Colestyramin als lipidsenker enthaltende präparate.
ES2109254T3 (es) Proteinas antigenas y vacunas que las contienen para la prevencion de cocidiosis.
NO982874L (no) Farmasöytiske preparater med vitamin D-analoger
DE69927602D1 (de) Verfahren zur herstellung von vitaminpulvern
DK198785A (da) 2-amino-3-ethoxycarbonylamino-6-(p-fluor-benzylamino)-pyridin-gluconatog farmaceutiske praeparater som indeholder dette stof
DE69434001D1 (de) Reinigung von vitamin-k abhaengigen proteinen durch membrane chromatographie
DK188286A (da) Phenylalkyl-2,3-dihydrobenzofuraner og analoge heraf samt praeparater indeholdende disse forbindelser
FI916120A0 (fi) Foerfarande foer framstaellning av vattenhaltiga liposomsuspensioner som innehaoller ett aktivt aemne.
ES2058056T3 (es) Procedimiento para la preparacion de cefodizim.
DK1001942T3 (da) Polyhydroxybutylpyraziner, deres fremstilling samt medikamenter indeholdende disse forbindelser
ATE33389T1 (de) Derivat eines ethers von n-propanolamin.
MX9102087A (es) Complejos que contienen acidos s(+) fenilalcanos y acidos alfa-hidroxi alcanos.
SE8002244L (sv) Nytt 1alfa,25-dihydroxi-cholekalciferolderivat, sett for framstellning samt anvendning derav som lekemedel och farmaceutiska kompositioner inehallande denna forening
JPS5291026A (en) Method of forming quinacridone beta-crystals
IT8321507A0 (it) Procedimento di preparazione fermentativa di l-leucina.
JPS5234981A (en) Production of alcohol from cellulose
FI852537A0 (fi) Foerfaranden och medel vid biologisk behandling.
JPS51118812A (en) A process for plasmin inhibitor concentration
FI851867A7 (fi) Membraania stabiloivat yhdisteet ja farmaseuttiset valmisteet sekä menetelmät näiden yhdisteiden käyttämiseksi.
IT8222481V0 (it) Quadro cartografico per uffici, scuole, tridimensionale.
JPS56117791A (en) Purification of kallikrein